Page last updated: 2024-10-25

eflornithine and Arthritis, Rheumatoid

eflornithine has been researched along with Arthritis, Rheumatoid in 2 studies

Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.

Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Geng, Z1
Ming, B1
Hu, S1
Dong, L1
Ye, C1
Benamouzig, R1
Chaussade, S1

Reviews

1 review available for eflornithine and Arthritis, Rheumatoid

ArticleYear
[Chemoprevention of colorectal cancer].
    Presse medicale (Paris, France : 1983), 2002, Jan-26, Volume: 31, Issue:3

    Topics: Adenomatous Polyposis Coli; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents;

2002

Other Studies

1 other study available for eflornithine and Arthritis, Rheumatoid

ArticleYear
α-Difluoromethylornithine suppresses inflammatory arthritis by impairing myeloid-derived suppressor cells.
    International immunopharmacology, 2019, Volume: 71

    Topics: Adoptive Transfer; Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Arthritis, Experimenta

2019